Canopy Biosciences
Canopy Biosciences is a private life science tools company founded in 2016 in St. Louis, Missouri, that accelerates commercialization of reagent tools and services through in-licensing, serving academic, biotech, and pharmaceutical customers with a 51–100 person team.
- Company typePrivate
- Founded2016
- HeadquartersSt Louis, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Canopy Biosciences does
Canopy Biosciences is a private, for-profit life science tools company founded in 2016 and headquartered in St. Louis, Missouri. Per the firmographic record, the company's stated strategy is to accelerate the commercialization of life science reagent tools and services through in-licensing, operating with 51–100 employees and a website at canopybiosciences.com. Leadership comprises co-founder and COO Crystal Winkeler and President & CEO Edward Weinstein, with a product marketing function led by Julie Leaderbrand.
The supplied data also presents an extensive product and technology profile that describes a comprehensive spatial biology portfolio — including the nCounter Analysis System, GeoMx Digital Spatial Profiler, CosMx Spatial Molecular Imager, CellScape XR Precise Spatial Proteomics, and PaintScape 3D Genome platforms, supported by assay panels (RNA, protein, multiomic), the AtoMx Spatial Informatics Platform, CRO laboratory services, and global Customer Experience Labs in Seattle and Amsterdam. However, these product, customer, and operational details are consistent with Bruker Spatial Biology, Inc. — a Bothell, Washington-based subsidiary of Bruker Corporation (NASDAQ: BRKR) that acquired NanoString's spatial biology unit — rather than the St. Louis-based Canopy Biosciences described in the firmographics. This internal inconsistency in the source data should be resolved before relying on any specific product or revenue claim.
Capital activity for Canopy Biosciences itself comprises approximately $4.4M raised across three rounds between 2017 and 2019, with Ampersand Capital Partners as a repeat investor and a broader 2018 syndicate (BioGenerator, Greenleaf Seed Fund, Kingdom Capital, Archangels, Missouri Technology Corporation, Pinpoint Holdings). The company executed two acquisitions in 2019 — Zellkraftwerk (April) and Core Diagnostics (December) — consistent with an in-licensing and roll-up approach to building a life science tools and services franchise. No post-2019 funding, headcount, or revenue updates are recorded.
Canopy Biosciences firmographics
Firmographics- Name
- Canopy Biosciences
- Legal name
- Bruker Spatial Biology, Inc.
- Website
- https://canopybiosciences.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Canopy Biosciences is a private life science tools company founded in 2016 in St. Louis, Missouri, that accelerates commercialization of reagent tools and services through in-licensing, serving academic, biotech, and pharmaceutical customers with a 51–100 person team.
- Ownership category
- akta.pro rank
Canopy Biosciences industry classification
Industry- Product category
- Spatial Biology Instrumentation
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Laboratory Analytical Instruments (3826), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)
Keywords
Where Canopy Biosciences is headquartered
LocationHeadquarters
- HQ city
- St Louis
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Canopy Biosciences business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations, Infrastructure
Revenue model
- Hardware Instruments: Sale of capital equipment including nCounter Analysis Systems, GeoMx Digital Spatial Profilers, CosMx Spatial Molecular Imagers, and CellScape platforms. These instruments are high-value capital purchases typically sold to enterprise customers through direct field sales.
- Consumables and Reagents: Recurring revenue from specialized assay panels, reagent kits, and consumables required for operation of the instruments. Includes RNA and protein assays, morphology markers, and custom solutions.
- Laboratory Services (CRO): Contract research organization services providing spatial biology analysis capabilities to customers who prefer outsourcing over instrument purchase.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels11 records
Canopy Biosciences product offering
Product offeringCore offering
Canopy Biosciences, operating as Bruker Spatial Biology, designs, manufactures, and sells spatial biology instrumentation platforms (nCounter, GeoMx DSP, CosMx SMI, CellScape XR, PaintScape) along with the consumable assay panels, reagents, and the AtoMx cloud informatics software that support them. The company also provides contract research organization (CRO) laboratory services and Customer Experience Labs in Seattle and Amsterdam for prospective customer evaluation and training. These offerings enable researchers to characterize tissues at bulk, single-cell, and subcellular resolution using transcriptomic, proteomic, and 3D genome readouts.
Product overview
Canopy Biosciences (operated as Bruker Spatial Biology) offers a comprehensive spatial biology ecosystem consisting of five integrated platform products: nCounter Analysis System for bulk multiomics, GeoMx Digital Spatial Profiler for discovery spatial profiling, CosMx Spatial Molecular Imager for single-cell subcellular imaging, CellScape XR for spatial proteomics, and PaintScape for 3D genome visualization. The portfolio includes complementary assay panels and reagents for RNA and protein analysis across all platforms, supported by data analysis solutions including AtoMx Spatial Informatics Platform and GeoMx Data Center. The platforms are designed to work together as an integrated ecosystem, enabling researchers to capture multiomic spatial data from discovery through translational research, with applications spanning oncology, immunology, neuroscience, infectious disease, and drug development.
Differentiator
Problem solved
Functional benefit
Brands
- nCounter: nCounter Analysis System for highly robust single or multiomics bulk analysis for rapid biomarker discovery and development
- GeoMx
- CosMx
- CellScape
- PaintScape
- AtoMx
- VistaPlex
Products and services
- nCounter Analysis System Highly robust single or multiomics bulk analysis instrument system for rapid biomarker discovery and development, including the nCounter Pro Analysis System and nCounter Sprint Profiler, supporting RNA and protein analysis from the same sample. Sold to biopharma, academic, and clinical research customers via direct enterprise sales.
- GeoMx Digital Spatial Profiler (DSP) Discovery multiomics instrument for spatially-guided transcriptomic and proteomic profiling of cells to tissue structures at scale. Used by research institutions and biopharma for biomarker discovery and translational research.
- CosMx Spatial Molecular Imager (SMI) High-sensitivity, subcellular imaging instrument that measures more than 19,000 RNAs and 64+ proteins from the same cell at single-cell resolution, enabling whole transcriptome and pathway-level spatial insights for oncology, neuroscience, and immunology research.
- CellScape XR Precise Spatial Proteomics Flexible subcellular proteomics instrument combining breakthroughs in instrumentation, software, and assays for rapid and quantitative spatial phenotyping at higher throughput. Targets researchers running multiplexed spatial proteomics studies on FFPE tissue.
- PaintScape System High-precision, multiplexed direct visualization system for 3D genome spatial analysis, enabling researchers to directly visualize 3D genome organization.
- AtoMx Spatial Informatics Platform (SIP) Cloud-based spatial informatics platform for management, analysis, and visualization of CosMx SMI and GeoMx DSP spatial data, providing researchers with shared data analysis and management capabilities across the instrument portfolio.
- nCounter Panels & Assays Ready-to-use gene expression consumables for the nCounter system, including RNA assays, protein assays, oncology and immunology panels, multiomics solutions, and custom assay development, sold as recurring revenue to instrument customers.
- GeoMx Panels & Assays RNA and protein assay panels for the GeoMx DSP, including morphology markers, spatial multiomics solutions, and custom assay development, sold as consumables tied to the installed GeoMx instrument base.
- CosMx Panels & Assays RNA and protein assay panels for the CosMx SMI, including the whole transcriptome panel, protein panels, same-cell multiomics panels, and custom solutions, sold as recurring consumables to instrument customers.
- VistaPlex Tissue Architecture Assay Kit Multiplexed assay kit for human FFPE tissue architecture analysis on the CellScape spatial proteomics platform, supporting spatial phenotyping of tissue structures.
- VistaPlex Spatial Immune Profiling Assay Kit Multiplexed assay kit for spatial immune profiling of human FFPE tissue samples on the CellScape platform.
- VistaPlex Cell Boundaries Assay Kit Multiplexed assay kit for cell boundary analysis of human FFPE tissue samples on the CellScape spatial proteomics platform.
- Laboratory Services (CRO) Contract research organization services providing spatial biology expertise and testing capabilities for customers who prefer outsourced analysis over purchasing capital instruments.
- Customer Experience Labs Hands-on laboratory experience and training facilities in Seattle and Amsterdam where prospective customers can evaluate spatial biology technologies and receive training prior to instrument purchase.
Quantifiable outcome
- 7,000+ peer-reviewed publications enabled by spatial biology technologies
Companies that use Canopy Biosciences
Customer profileNamed customers9 records
Segments4 records
Ideal customer profiles4 records
Canopy Biosciences technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature7 records
Canopy Biosciences partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- Human Cell Atlas ProjectcoreCollaboration with Human Cell Atlas consortium researchers to generate organ atlases of the healthy human system. CosMx SMI technology used to visualize single-cell reference maps directly in organs, contributing to comprehensive cell reference maps.
- Harvard Corporation (President and Fellows of Harvard College)coreLicensed intellectual property (EP 2 794 928 B1) for FISH-based RNA detection methods. The patent is required for operation of CosMx SMI technology in certain territories including Germany.
- GeoMx Partners EcosystemcoreTechnology and integration partners for the GeoMx Digital Spatial Profiler platform, enabling expanded capabilities and interoperability with complementary research tools and data analysis solutions.
- Contract Research Organizations (CROs)coreNetwork of CRO partners providing spatial biology services using Bruker Spatial Biology platforms, enabling customers to access capabilities without direct instrument purchase.
- Global DistributorsminorGlobal distributor network expanding market reach and providing local sales and support capabilities in regions outside direct sales coverage.
Scale indicators1 record
Recent moves6 records
Expansion highlights5 records
Canopy Biosciences competitors and assessment
Company assessmentDirect peers
- 10x Genomics: Leading spatial biology competitor offering Visium (tissue-level) and Xenium (single-cell/subcellular) platforms that directly compete with GeoMx DSP and CosMx SMI for spatial transcriptomics customers across pharma and academia.
- NanoString Technologies: Original inventor and owner of nCounter, GeoMx DSP, and CosMx SMI platforms prior to the 2024 Bruker acquisition; post-restructuring it remains a direct competitor with overlapping spatial biology offerings and an installed base of legacy users.
- Vizgen: Developer of the MERFISH-based MERSCOPE platform for single-cell spatial transcriptomics; directly competes with CosMx SMI in the subcellular, high-plex imaging segment.
- Akoya Biosciences: Offers the PhenoCycler (CODEX) and Phenoptics spatial biology platforms for highly multiplexed tissue imaging; competes with CellScape and GeoMx in spatial proteomics and immuno-oncology applications.
- Standard BioTools (now Stellular): Provider of the Hyperion Imaging Mass Cytometry platform for spatial proteomics at subcellular resolution; competes with GeoMx DSP and CellScape in translational and immuno-oncology research.
- Bio-Techne: Spatial biology player via the RNAscope/ACD and Advanced Cell Diagnostics franchises, with growing multiplex spatial assays; competes in spatial transcriptomics adjacent to nCounter and CosMx workflows.
Broad incumbents
- Illumina: Diversified sequencing incumbent with bulk and emerging single-cell/spatial capabilities; serves overlapping pharma and academic customers but does not currently match CosMx/GeoMx subcellular resolution imaging.
- Revvity (formerly PerkinElmer Life Sciences): Life sciences tools incumbent offering multiplexed imaging and spatial workflows through its Cell Biology and Software franchises; broader portfolio with overlapping translational/clinical research customers.
Emerging players
- Singular Genomics: Developer of the G4 sequencing platform with emerging spatial biology ambitions; an emerging competitor that could intersect with spatial transcriptomics workflows over time.
Others
- Bruker Corporation: Parent company and corporate owner of Bruker Spatial Biology; provides corporate infrastructure, global distribution, and adjacent instruments (proteomics, microscopy) that frame the spatial biology unit's strategic context.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Canopy Biosciences social profiles
Digital presenceCanopy Biosciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
Canopy Biosciences leadership team
Management profileNumber of profiles
Profiles3 records
Canopy Biosciences funding detail
Funding detailFunding overview
Funding rounds3 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Canopy Biosciences M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Canopy Biosciences
What does Canopy Biosciences do?
Canopy Biosciences, operating as Bruker Spatial Biology, designs, manufactures, and sells spatial biology instrumentation platforms (nCounter, GeoMx DSP, CosMx SMI, CellScape XR, PaintScape) along with the consumable assay panels, reagents, and the AtoMx cloud informatics software that support them. The company also provides contract research organization (CRO) laboratory services and Customer Experience Labs in Seattle and Amsterdam for prospective customer evaluation and training. These offerings enable researchers to characterize tissues at bulk, single-cell, and subcellular resolution using transcriptomic, proteomic, and 3D genome readouts.
Is Canopy Biosciences a public or private company?
Canopy Biosciences is a private company. It is classified as corporate owned and is currently operating.
When was Canopy Biosciences founded?
Canopy Biosciences was founded in 2016. It employs 51 to 100 people.
Where is Canopy Biosciences based?
Canopy Biosciences is headquartered in St Louis, United States, in the North America region.
How does Canopy Biosciences make money?
Three revenue lines are on record. Hardware Instruments are the primary driver. The others are consumables and Reagents and laboratory Services (CRO).
Who are Canopy Biosciences's main competitors?
Direct peers on record are 10x Genomics, NanoString Technologies, Vizgen, Akoya Biosciences, Standard BioTools (now Stellular) and Bio-Techne. Broad incumbents are Illumina and Revvity (formerly PerkinElmer Life Sciences). Singular Genomics is listed as an emerging player. Bruker Corporation is listed as an others.
Does Canopy Biosciences have an API?
No public API is recorded for Canopy Biosciences.
What industry is Canopy Biosciences in?
Canopy Biosciences's product category is Spatial Biology Instrumentation. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments. Its NAICS code is 334516 and its SIC code is 3826.